US Patent Issued to Dyne Therapeutics on May 12 for "Anti-transferrin receptor (TfR) antibody and uses thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,624,120, issued on May 12, was assigned to Dyne Therapeutics Inc. (Waltham, Mass.).

"Anti-transferrin receptor (TfR) antibody and uses thereof" was invented by Romesh R. Subramanian (Framingham, Mass.), Mohammed T. Qatanani (Waltham, Mass.), Timothy Weeden (Waltham, Mass.), Cody A. Desjardins (Waltham, Mass.) and Brendan Quinn (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "Aspects of the disclosure relate to antibodies that bind to transferrin receptor (e.g., transferrin receptor 1) and complexes comprising the antibody covalently linked to a molecular payload. Methods of making and using the antibodies are also provided."

The patent was filed o...